CTRI/2023/05/052248
Not yet recruiting
Phase 4
Pharmaceutical analytical and clinical study of shalmali ghrita w.s.r. to Shweta pradara(leucorrhoea)
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Health Condition 1: N899- Noninflammatory disorder of vagina, unspecified
- Sponsor
- Shubhdeep ayurved medical college
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •(1\) Female patients of age between 20 to 50 years.
- •(2\)Non\-specific leucorrhoea.
Exclusion Criteria
- •(1\) Abnormal uterine bleeding.
- •(2\)Local gynaecological causes like ovarian cyst, prolapsed uterus, cervicitis, carcinoma, fibromyoma and polyps.
- •(3\)Systemic disease including diabetes mellitus, anemia, HIV and others.
- •(4\)Patients with STD.
- •(5\)Lactating mother.
- •(6\)Pregnancy
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 3
Compare the effect of two medicines sudha parpati and shankha bhasma on pimplesHealth Condition 1: - Health Condition 2: 3- AdministrationHealth Condition 3: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhereHealth Condition 4: L988- Other specified disorders of the skin and subcutaneous tissueCTRI/2023/10/058523Dr.Shamja C Shamsudheen
Recruiting
Phase 2
Preparation of soap and cream with medicated Trinak oil and its clinical trial in skin disease.Health Condition 1: L089- Local infection of the skin and subcutaneous tissue, unspecifiedCTRI/2023/10/058304Shri Krishna Govt Ayurvedic College and Hospital
Not yet recruiting
Not Applicable
To study the effect of â??Dashemani Kandughna Gelâ?? local application in the management of Dandruff ( itching over scalp, Flakes on scalp etc)Health Condition 1: L00-L99- Diseases of the skin and subcutaneous tissueCTRI/2020/12/030010Dr Nilima Sanjay Dharkar
Not yet recruiting
Phase 2
To study and evaluate the efficacy of Manjishthadi Tail and Manjishthadi Cream in the management of Acne.CTRI/2022/06/043539IA
Completed
Not Applicable
Clinical investigation of therapeutic effects of sorafenib on cutaneous angiosarcomaAngiosarcomaJPRN-UMIN000017373Taku Fujimura2